4.5 Article

Exploring the Value of Plasma BIN1 as a Potential Biomarker for Alzheimer's Disease

期刊

JOURNAL OF ALZHEIMERS DISEASE
卷 37, 期 2, 页码 291-295

出版社

IOS PRESS
DOI: 10.3233/JAD-130392

关键词

Alzheimer's disease; BIN1; biomarker; ELISA; plasma; qRT-PCR

资金

  1. National Natural Science Foundation of China [81000544, 81171209]
  2. Shandong Provincial Natural Science Foundation, China [ZR2010HQ004, ZR2011HZ001]

向作者/读者索取更多资源

BIN1, as an important genetic susceptibility locus in late-onset Alzheimer's disease (AD), is overexpressed in AD brains. Our study investigated BIN1 diagnostic value by quantifying its transcription level and plasma expression from 112 AD and 200 control subjects. We observed significant increase in BIN1 mRNA and protein levels in AD patients. Receiver operating characteristic curve analysis shown the sensitivity and specificity were 73% and 75% for plasma BIN1 in identifying AD. Although this is a pilot study requiring corroboration on a larger cohort of patients, our results highlight the possible use of plasma BIN1 as a biomarker for AD diagnosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

Tau Toxicity in Neurodegeneration

Shu-Yu Liang, Zuo-Teng Wang, Lan Tan, Jin-Tai Yu

Summary: This article introduces the function and dysfunction of microtubule-associated protein tau in the central nervous system and discusses its role in neurodegenerative diseases, tau phosphorylation-related enzymes and proteins, and its relationship with cell dysfunction. The study of tau neurotoxicity provides new directions for the treatment of tauopathies.

MOLECULAR NEUROBIOLOGY (2022)

Review Neurosciences

Tauopathies: new perspectives and challenges

Yi Zhang, Kai-Min Wu, Liu Yang, Qiang Dong, Jin-Tai Yu

Summary: In this article, emerging knowledge on tauopathies from clinical, pathological, genetic, and experimental studies is synthesized to accelerate the development of therapeutics for these diseases. The focus is on depicting pathological characteristics, identifying biomarkers, elucidating the underlying pathogenesis for early diagnosis, and the development of disease-modifying therapies.

MOLECULAR NEURODEGENERATION (2022)

Article Environmental Sciences

Residential greenness and risk of incident dementia: A prospective study of 375,342 participants

He-Ying Hu, Ya-Hui Ma, Yue-Ting Deng, Ya-Nan Ou, Wei Cheng, Jian-Feng Feng, Lan Tan, Jin-Tai Yu

Summary: This study found an association between residential greenness and dementia incidence, indicating that increasing greenspace can reduce the risk of dementia. The protective effect of greenness may be mediated through the reduction of particulate air pollution.

ENVIRONMENTAL RESEARCH (2023)

Article Clinical Neurology

Genetic determinants of circulating metabolites and the risk of stroke and its subtypes

Rong-Ze Wang, Shu-Yi Huang, Hong-Qi Li, Yu-Xiang Yang, Shi-Dong Chen, Jin-Tai Yu

Summary: Using a Mendelian randomization approach, this study found that genetically determined levels of lipids in small LDL were associated with the risk of stroke, especially large-artery atherosclerotic stroke. Higher cholesterol levels in high-density lipoprotein (HDL-C) were associated with the risk of intracerebral haemorrhage. However, no significant association was found between genetic predisposition to circulating metabolites and magnetic resonance imaging markers of cerebral small vessel disease and microstructural injury.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Review Biochemistry & Molecular Biology

Omics-based biomarkers discovery for Alzheimer's disease

Qiaolifan Aerqin, Zuo-Teng Wang, Kai-Min Wu, Xiao-Yu He, Qiang Dong, Jin-Tai Yu

Summary: This review summarizes the progress made in the discovery of reliable Alzheimer's disease (AD) biomarkers using genomics, transcriptomics, proteomics, and metabolomics. The importance of these biomarkers in the diagnosis and treatment of AD is discussed.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Medicine, General & Internal

Hearing impairment is associated with cognitive decline, brain atrophy and tau pathology

Hui-Fu Wang, Wei Zhang, Edmund T. Rolls, Yuzhu Li, Linbo Wang, Ya-Hui Ma, Jujiao Kang, Jianfeng Feng, Jin-Tai Yu, Wei Cheng

Summary: This study investigated the association of hearing performance with cognitive function, brain structure, and cerebrospinal fluid (CSF) proteins. The findings revealed that poor hearing performance was related to worse cognitive function, brain atrophy, and tau pathology.

EBIOMEDICINE (2022)

Review Clinical Neurology

A new ERBB4 variant in amyotrophic lateral sclerosis type 19: Case report and review of the literature

Na Zhang, Ke-Liang Chen, Yu-Yuan Huang, Shu-Fen Chen, Qiang Dong, Lan Tan, Jin-Tai Yu

CLINICAL NEUROLOGY AND NEUROSURGERY (2023)

Article Neurosciences

Association of rs2062323 in the TREM1 gene with Alzheimer's disease and cerebrospinal fluid-soluble TREM2

Zuo-Teng Wang, Yan Fu, Shi-Dong Chen, Yu-Yuan Huang, Ya-Hui Ma, Yan-Jiang Wang, Lan Tan, Jin-Tai Yu

Summary: This study is the first to identify significant associations between TREM1 rs2062323 and AD risk. The rs2062323T may be involved in AD by regulating the expression of TREM1, TREML1, TREM2, and sTREM2. The TREM family is expected to be a potential therapeutic target for AD.

CNS NEUROSCIENCE & THERAPEUTICS (2023)

Article Clinical Neurology

Associations of Life's Simple 7 with cerebral white matter hyperintensities and microstructural integrity: UK Biobank cohort study

Yan Fu, Yan Sun, Zhi-Bo Wang, Dan-Dan Zhang, Lan Tan, Jian-Feng Feng, Wei Cheng, Jin-Tai Yu

Summary: This study used the American Heart Association's Life's Simple 7 (LS7) metric to define cardiovascular and brain health and found that ideal LS7 cardiovascular health factors are associated with both macrostructural and microstructural markers of brain health. The results suggest that better LS7 profiles are linked to better brain health.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Biochemistry & Molecular Biology

Associations of circulating metabolites with cerebral white matter hyperintensities

Yan Sun, Yu Guo, Hong-Qi Li, Lan Tan, Jian-Feng Feng, Wei Cheng, Jin-Tai Yu

Summary: White matter hyperintensities (WMH) are strongly associated with stroke, dementia, and early mortality. This study investigated the relationship between WMH and circulating metabolites in a large sample of individuals from the UK Biobank. The results showed that several metabolites, including high-density lipoprotein (HDL), fatty acids, and glycoprotein acetyls, were associated with WMH. Age and sex also had a significant influence on these associations. The findings suggest that specific metabolomic features accompany WMH and may provide insights into the implications of WMH in different populations.

JOURNAL OF NEUROCHEMISTRY (2023)

Article Geriatrics & Gerontology

Circulating polyunsaturated fatty acids, fish oil supplementation, and risk of incident dementia: a prospective cohort study of 440,750 participants

Yu He, Shu-Yi Huang, Hui-Fu Wang, Wei Zhang, Yue-Ting Deng, Ya-Ru Zhang, Qiang Dong, Jian-Feng Feng, Wei Cheng, Jin-Tai Yu

Summary: Cohort studies have shown inconsistent associations between omega-3 polyunsaturated fatty acids (n-3 PUFA) or fish oil and dementia risk. This study included a large number of participants and found that higher plasma levels of PUFA and fish oil supplementation were associated with a lower risk of developing dementia.

GEROSCIENCE (2023)

Article Biochemistry & Molecular Biology

Circulating metabolites and risk of incident dementia: A prospective cohort study

Shu-Yi Huang, Ya-Ru Zhang, Liu Yang, Yu-Zhu Li, Bang-Sheng Wu, Shi-Dong Chen, Jian-Feng Feng, Qiang Dong, Wei Cheng, Jin-Tai Yu

Summary: Identifying circulating metabolites associated with dementia, cognition, and brain volume could provide new insights into the pathogenesis of dementia. This cohort study found 26 metabolites associated with incident dementia, including specific associations with Alzheimer's disease (AD) and vascular dementia (VD). Circulating levels of certain lipoproteins were found to be associated with the risk of AD and AD phenotypes, while another lipoprotein was associated with the risk of VD.

JOURNAL OF NEUROCHEMISTRY (2023)

Article Biochemistry & Molecular Biology

The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study

Ji-Yun Cheng, Yue-Ting Deng, Jin-Tai Yu

Summary: Through a more robust analysis, we found potential associations between circulating levels of amino acids and the risk of neurodegenerative diseases. Increase in circulating levels of Glutamine (Gln) was associated with lower risk of Alzheimer's disease (AD), while increase in circulating levels of Leucine (Leu) was associated with lower risk of Parkinson's disease (PD). Replication tests further confirmed the potential association between circulating Gln levels and AD risk.

JOURNAL OF NEUROCHEMISTRY (2023)

Article Neurosciences

Inflammation and Brain Structure in Alzheimer's Disease and Other Neurodegenerative Disorders: a Mendelian Randomization Study

Wei-Shi Liu, Ya-Ru Zhang, Yi-Jun Ge, Hui-Fu Wang, Wei Cheng, Jin-Tai Yu

Summary: This study identified the association between TREM2, temporal lobe, and AD using genetic and transcriptomic data, and explored the complex associations among inflammation, brain structure, and neurodegenerative disorders, particularly AD.

MOLECULAR NEUROBIOLOGY (2023)

Review Neurosciences

TMEM106B aggregation in neurodegenerative diseases: linking genetics to function

Hai-Shan Jiao, Peng Yuan, Jin-Tai Yu

Summary: Mutations in the TMEM106B gene are risk factors for various neurodegenerative diseases. Previous understanding of the underlying mechanism focused on the impairment of lysosome biogenesis caused by TMEM106B loss-of-function. However, mutations in TMEM106B increase its expression level, thus the molecular process linking these mutations to the apparent disruption in TMEM106B function remains mysterious.

MOLECULAR NEURODEGENERATION (2023)

暂无数据